May 14, 2015      

ReWalk Robotics Ltd.'s stock has dropped from a high of $43.71 per share last year to $10.66 as of last week, as investors have questioned its ability to sell its exoskeleton. At its initial public offering in September 2014, stocks were offered at $12 per share, and the company raised $36 million.

The Yokneam, Israel-based medical device company reported revenue of only $640,000 for the quarter, compared with the consensus estimate of $2.2 million, but its revenue was up 42.7 percent compared ...

Thank You for Reading Robotics Business Review!

Reading this content requires a free membership.
To continue reading, please sign up for an RBR Insider account.